Berino, Ma Corazon E.

HRN: 23-82-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/02/2023
10/08/2023
IV
4.5g LD, Then 2.25g
Q8h
CAP HR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: